Computational insights into a protease inhibitor from Streptomyces globosus VITSMAB-2 molecular docking and dynamics simulations against SARS-CoV-2 main protease.

Computational insights into a protease inhibitor from Streptomyces globosus VITSMAB-2 molecular docking and dynamics simulations against SARS-CoV-2 main protease.

Publication date: Dec 13, 2025

Open Access PDF

Concepts Keywords
Docking ADMET
Informatics Cysteine protease inhibitor
Molecular Molecular docking
Protease Phenyl carbamate
Streptomyces SARS-CoV-2 main protease.
Streptomyces globosus VITSMAB-2

Semantics

Type Source Name
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Aspartame
pathway KEGG Viral replication
drug DRUGBANK L-Cysteine
drug DRUGBANK Serine
drug DRUGBANK Papain
drug DRUGBANK Trypsin
pathway REACTOME Metabolism
disease MESH common cold
disease MESH Middle East Respiratory Syndrome
disease MESH severe acute respiratory syndrome
disease MESH COVID 19
drug DRUGBANK Histidine
pathway KEGG Influenza A
disease MESH Park
disease MESH strains
drug DRUGBANK Water
drug DRUGBANK Tromethamine
drug DRUGBANK Acetic acid
drug DRUGBANK Lysozyme
drug DRUGBANK Ethanol
drug DRUGBANK Minaprine
drug DRUGBANK Aluminium
drug DRUGBANK Medical air
disease MESH PDA
drug DRUGBANK Silicon dioxide
drug DRUGBANK Coenzyme M

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *